The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Construction of an Excisable Bacterial Artificial Chromosome Containing a Full-Length Infectious Clone of Herpes Simplex Virus Type 1: Viruses Reconstituted from the Clone Exhibit Wild-Type Properties In Vitro and In Vivo
Open accessAbstract
In recent years, several laboratories have reported on the cloning of herpes simplex virus type 1 (HSV-1) genomes as bacterial artificial chromosomes (BACs) in Escherichia coli and on procedures to manipulate these genomes by using the bacterial recombination machinery. However, the HSV-BACs reported so far are either replication incompetent or infectious, with a deletion of one or more viral genes due to the BAC vector insertion. For use as a multipurpose clone in research on HSV-1, we attempted to generate infectious HSV-BACs containing the full genome of HSV-1 without any loss of viral genes. Our results were as follows. (i) E. coli (YEbac102) harboring the full-length HSV-1 genome (pYEbac102) in which a BAC flanked by loxP sites was inserted into the intergenic region between U L 3 and U L 4 was constructed. (ii) pYEbac102 was an infectious molecular clone, given that its transfection into rabbit skin cells resulted in production of infectious virus (YK304). (iii) The BAC vector sequence was almost perfectly excisable from the genome of the reconstituted virus YK304 by coinfection of Vero cells with YK304 and a recombinant adenovirus, AxCANCre, expressing Cre recombinase. (iv) As far as was examined, the reconstituted viruses from pYEbac102 could not be phenotypically differentiated from wild-type viruses in vitro and in vivo. Thus, the viruses grew as well in Vero cells as did the wild-type virus and exhibited wild-type virulence in mice on intracerebral inoculation. (v) The infectious molecular clone pYEbac102 is in fact useful for mutagenesis of the HSV-1 genome by bacterial genetics, and a recombinant virus carrying amino acid substitutions in both copies of the α0 gene was generated. pYEbac102 will have multiple applications to the rapid generation of genetically engineered HSV-1 recombinants in basic research into HSV-1 and in the development of HSV vectors in human therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
Selective extraction of polyoma DNA from infected mouse cell cultures
Hirt, B. (1967) · Journal of Molecular Biology · doi:10.1016/0022-2836(67)90307-5 · Cited by 5,146
Whitley, R. J., Kimberlin, D. W., & Roizman, B. (1998) · Clinical Infectious Diseases · doi:10.1086/514600 · Cited by 1,149
Markert, J. M., Medlock, M. D., Rabkin, S. D., Gillespie, G. Y., Todo, T., Hunter, W. D., Palmer, C. A., Feigenbaum, F., Tornatore, C., Tufaro, F., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301205 · Cited by 976
Ejercito, P. M., Kieff, E. D., & Roizman, B. (1968) · Journal of General Virology · doi:10.1099/0022-1317-2-3-357 · Cited by 875
Link, A. J., Phillips, D., & Church, G. M. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.20.6228-6237.1997 · Cited by 874
Whitley, R. J., & Roizman, B. (2002) · Wiley Encyclopedia of Molecular Medicine · doi:10.1002/0471203076.emm0597 · Cited by 700
Kanegae, Y., Lee, G., Sato, Y., Tanaka, M., Nakal, M., Sakaki, T., Sugano, S., & Saito, I. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.19.3816 · Cited by 606
Self-citationRampling, R., Cruickshank, G., Papanastassiou, V, Nicoll, J., Hadley, D., Brennan, D., Petty, R., MacLean, A., Harland, J., McKie, E., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301184 · Cited by 598
Bacteriophage P1 site-specific recombination
Sternberg, N., & Hamilton, D. (1981) · Journal of Molecular Biology · doi:10.1016/0022-2836(81)90375-2 · Cited by 579
The herpes simplex virus amplicon: A new eucaryotic defective-virus cloning-amplifying vector
Spaete, R. (1982) · Cell · doi:10.1016/0092-8674(82)90035-6 · Cited by 508
Propagation and recovery of intact, infectious Epstein–Barr virus from prokaryotic to human cells
Delecluse, H.-J., Hilsendegen, T., Pich, D., Zeidler, R., & Hammerschmidt, W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8245 · Cited by 467
Post, L. E., Mackem, S., & Roizman, B. (1981) · Cell · doi:10.1016/0092-8674(81)90346-9 · Cited by 442
Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome
Messerle, M., Crnkovic, I., Hammerschmidt, W., Ziegler, H., & Koszinowski, U. H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14759 · Cited by 426
Borst, E.-M., Hahn, G., Koszinowski, U. H., & Messerle, M. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8320-8329.1999 · Cited by 384
Post, L. E., & Roizman, B. (1981) · Cell · doi:10.1016/0092-8674(81)90247-6 · Cited by 336
The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice
Field, H. J., & Wildy, P. (1978) · Journal of Hygiene · doi:10.1017/s0022172400025109 · Cited by 334
Human Cytomegalovirus with IE-2 (UL122) Deleted Fails To Express Early Lytic Genes
Marchini, A., Liu, H., & Zhu, H. (2001) · Journal of Virology · doi:10.1128/jvi.75.4.1870-1878.2001 · Cited by 332
Wagner, M., Jonjić, S., Koszinowski, U. H., & Messerle, M. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.7056-7060.1999 · Cited by 320
Adler, H., Messerle, M., Wagner, M., & Koszinowski, U. H. (2000) · Journal of Virology · doi:10.1128/jvi.74.15.6964-6974.2000 · Cited by 317
Cocchi, F., Menotti, L., Mirandola, P., Lopez, M., & Campadelli-Fiume, G. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9992-10002.1998 · Cited by 281
Yu, D., Smith, G. A., Enquist, L. W., & Shenk, T. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2316-2328.2002 · Cited by 259
Kawaguchi, Y., Van Sant, C., & Roizman, B. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.7328-7336.1997 · Cited by 245
Self-citationZhou, F.-C., Zhang, Y.-J., Deng, J.-H., Wang, X.-P., Pan, H.-Y., Hettler, E., & Gao, S.-J. (2002) · Journal of Virology · doi:10.1128/jvi.76.12.6185-6196.2002 · Cited by 239
McKnight, J. L., Kristie, T. M., & Roizman, B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7061 · Cited by 214
A Cosmid-Based System for Constructing Mutants of Herpes Simplex Virus Type 1
Cunningham, C., & Davison, A. J. (1993) · Virology · doi:10.1006/viro.1993.1572 · Cited by 201
The use of DNA viruses as vectors for gene therapy.
Ali, M., Lemoine, N. R., & Ring, C. (1994) · PubMed · Cited by 200
Saeki, Y., Ichikawa, T., Saeki, A., Chiocca, E. A., Tobler, K., Ackermann, M., Breakefield, X. O., & Fraefel, C. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.18-2787 · Cited by 200
Smith, G. A., & Enquist, L. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080502497 · Cited by 200
An Enhanced Packaging System for Helper-Dependent Herpes Simplex Virus Vectors
Stavropoulos, T. A., & Strathdee, C. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7137-7143.1998 · Cited by 186
Kawaguchi, Y., Bruni, R., & Roizman, B. (1997) · Journal of Virology · doi:10.1128/jvi.71.2.1019-1024.1997 · Cited by 181
Self-citationBaines, J. D., & Roizman, B. (1991) · Journal of Virology · doi:10.1128/jvi.65.2.938-944.1991 · Cited by 176
He, B., Chou, J., Liebermann, D. A., Hoffman‐Liebermann, B., & Roizman, B. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.84-90.1996 · Cited by 140
Brune, W., Messerle, M., & Koszinowski, U. H. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(00)02015-1 · Cited by 123
Horsburgh, B. C., Hubinette, M., Qiang, D., et al. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300887 · Cited by 106
Kawaguchi, Y., Sant, C. V., & Roizman, B. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.1731-1736.1998 · Cited by 85
Self-citationKawaguchi, Y., Tanaka, M., Yokoymama, A., Matsuda, G., Kato, K., Kagawa, H., Hirai, K., & Roizman, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1877 · Cited by 81
Self-citationGenetically engineered human herpes simplex virus in the treatment of brain tumours.
Markert, J. M., Jn, P., Gillespie, G. Y., & Whitley, R. J. (2001) · PubMed · Cited by 33
Kawaguchi, Y. (2001) · Medical Entomology and Zoology · Cited by 33
Self-citation
Cited by
Resistance of Herpes Simplex Viruses to Nucleoside Analogues: Mechanisms, Prevalence, and Management
Piret, J., & Boivin, G. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00615-10 · Cited by 558
PILRα Is a Herpes Simplex Virus-1 Entry Coreceptor That Associates with Glycoprotein B
Satoh, T., Arii, J., Suenaga, T., Wang, J., Kogure, A., Uehori, J., Arase, N., Shiratori, I., Tanaka, S., Kawaguchi, Y., et al. (2008) · Cell · doi:10.1016/j.cell.2008.01.043 · Cited by 298
Self-citationTanaka, M., Sata, T., & Kawaguchi, Y. (2008) · Virology Journal · doi:10.1186/1743-422x-5-125 · Cited by 39
Self-citation
Metadata
- Authors
- Tanaka, M., Kagawa, H., Yamanashi, Y., Sata, T., & Kawaguchi, Y.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2003-01-15
- Volume
- 77
- Issue
- 2
- Pages
- 1382-1391
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2147469769
- Cited by
- 292
- References
- 39
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.